283 related articles for article (PubMed ID: 28566719)
1. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.
Yan G; Wang X; Sun C; Zheng X; Wei H; Tian Z; Sun R
Sci Rep; 2017 May; 7(1):2567. PubMed ID: 28566719
[TBL] [Abstract][Full Text] [Related]
2. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
3. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
[TBL] [Abstract][Full Text] [Related]
4. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.
Brandon-Warner E; Walling TL; Schrum LW; McKillop IH
Alcohol Clin Exp Res; 2012 Apr; 36(4):641-53. PubMed ID: 22017344
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.
Mercer KE; Hennings L; Sharma N; Lai K; Cleves MA; Wynne RA; Badger TM; Ronis MJ
Cancer Prev Res (Phila); 2014 Jul; 7(7):675-85. PubMed ID: 24778325
[TBL] [Abstract][Full Text] [Related]
6. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
[TBL] [Abstract][Full Text] [Related]
7. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
8. The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.
Sheppard S; Guedes J; Mroz A; Zavitsanou AM; Kudo H; Rothery SM; Angelopoulos P; Goldin R; Guerra N
Nat Commun; 2017 Jan; 8():13930. PubMed ID: 28128200
[TBL] [Abstract][Full Text] [Related]
9. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
11. Diethylnitrosamine Induction of Hepatocarcinogenesis in Mice.
Sotty J; Bablon P; Weiss PH; Soussan P
Methods Mol Biol; 2024; 2769():15-25. PubMed ID: 38315386
[TBL] [Abstract][Full Text] [Related]
12. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
13. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
15. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
16. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
18. Maternal Consumption of a Low-Isoflavone Soy Protein Isolate Diet Accelerates Chemically Induced Hepatic Carcinogenesis in Male Rat Offspring.
Choi J; Won SB; Kwon YH
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32098370
[TBL] [Abstract][Full Text] [Related]
19. Effect of alcohol on diethylnitrosamine-induced hepatic toxicity: Critical role of ROS, lipid accumulation, and mitochondrial dysfunction.
Sun Q; Long Z; Wu H; Liu Y; Wang L; Zhang X; Wang X; Hai C
Exp Toxicol Pathol; 2015 Oct; 67(10):491-8. PubMed ID: 26198575
[TBL] [Abstract][Full Text] [Related]
20. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
